Drug Type Small molecule drug |
Synonyms AVE 2268, AVE-2268, AVE2268 |
Target |
Action inhibitors |
Mechanism SGLT2 inhibitors(Sodium/glucose cotransporter 2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Molecular FormulaC18H22O7S |
InChIKeyBUXGTLNOWLNUKF-SOVHRIKKSA-N |
CAS Registry647834-15-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 2 | Argentina | 01 Jul 2006 | |
Diabetes Mellitus, Type 2 | Phase 2 | Australia | 01 Jul 2006 | |
Diabetes Mellitus, Type 2 | Phase 2 | Belgium | 01 Jul 2006 | |
Diabetes Mellitus, Type 2 | Phase 2 | Chile | 01 Jul 2006 | |
Diabetes Mellitus, Type 2 | Phase 2 | Denmark | 01 Jul 2006 | |
Diabetes Mellitus, Type 2 | Phase 2 | France | 01 Jul 2006 | |
Diabetes Mellitus, Type 2 | Phase 2 | Germany | 01 Jul 2006 | |
Diabetes Mellitus, Type 2 | Phase 2 | Italy | 01 Jul 2006 | |
Diabetes Mellitus, Type 2 | Phase 2 | Netherlands | 01 Jul 2006 | |
Diabetes Mellitus, Type 2 | Phase 2 | Poland | 01 Jul 2006 |